News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eleven Biotherapeutics to Present at the Targeting Ocular Disorders Conference


9/24/2013 9:46:12 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today that Eric Furfine, Ph.D., Eleven’s Chief Scientific Officer, is scheduled to present at the Targeting Ocular Disorders Conference being held September 26-27, 2013 in Boston, MA. The presentation, entitled ‘Inhibition of Cytokine Signaling to Treat Ocular Diseases,’ will take place on Friday, September 27, 2013 at 2:20 p.m. ET during the Looking to the Future session which Dr. Furfine will also chair.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES